Lopansri Cheraphat MD - CA Los Angeles, Monterey Park 91754

Lopansri Cheraphat MD entered the industry of Dermatologists in 1981 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Dermatologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Dermatologists. The business provides service to the B2C market.

To acquire more information, please contact Cheraphat Lopansri by calling (626) 573-5005 during business hours. You can also write to the business’ Single Location at 223 North Garfield Avenue # 306, Monterey Park, California CA 91754. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Lopansri Cheraphat MD
Representative: Cheraphat Lopansri
Place of Business: 223 North Garfield Avenue # 306, Monterey Park, CA 91754
Contact Number: (626) 573-5005
Type of Service: Dermatologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1981
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Lopansri Cheraphat MD is a company operating from Los Angeles, California providing professional Dermatologists and relevant B2C variables. It was founded in 1981 and registered with the SIC code 8011 as Dermatologists, and with the NAICS code 6211110 as Dermatologists.

With a current employee count of 1 to 4, Lopansri Cheraphat MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Cheraphat Lopansri at (626) 573-5005 for related queries, or to locate its Single Location using the coordinates 34.064023,-118.122908.

The Single Location can also be found at the street address 223 North Garfield Avenue # 306 in Monterey Park, California 91754 and can be engaged online through the company website at , the company Twitter , and Facebook page .